Herein we report the synthesis and structural characterization of a series of novel Zr(IV)salan complexes. The initial metalation product We recently found the functionalization of titanium(IV) salan alkoxides 14 with the dianionic tridentate pyridine-2,6-dicarboxylic acid (dipic) is leading to rigid heptacoordinate Ti(IV)-complexes.
Stimulated by the discovery of tumor-inhibiting effects of titanocene dichloride 1 by other metallocene halides of V, 2 Nb, 3 Mo, 4 W, 3 Zr and Hf 5 were screened for their anti-tumoral activity in short succession. During the following years research was mainly focused on the development of titanium based drugs while the heavier congener zirconium received considerably less attention. Propelled by the early success of titanocene dichloride other ligand systems like diketonates were investigated and the early development phase of group-IV metal based anti-tumor drugs finally climaxed in clinical trials of budotitane (Ti(bzac) 2 (OEt) 2 ; bzac = phenylbutane-1,3-dione) 6 and titanocene dichloride. 7 Further clinical studies were discouraged mainly due to cardiotoxic side effects and formulation problems associated with premature hydrolysis of the complexes under physiological conditions. 6b,8 Surprisingly, reports on anti-tumor active zirconium complexes are rather sparse and do not reflect the rich variety of ligand systems available for titanium. With the exception of zirconium 1,3-diketonates 9 and an amino functionalized ionic zirconocene dichloride, 10 no other structurally well-defined anti-tumor active zirconium complexes are known yet. Salans are hydrogenated N,N 0 -bis(salicylidene)ethylenediamine (salen) ligands with [ONNO]-binding motif and variable substitution pattern at nitrogen. 11 They are known to form zirconium bis(alkoxides) which are intensely investigated as catalysts in the polymerization of olefins 12 and lactide.
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We recently found the functionalization of titanium(IV) salan alkoxides 14 with the dianionic tridentate pyridine-2,6-dicarboxylic acid (dipic) is leading to rigid heptacoordinate Ti(IV)-complexes.
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These hetero-bis-chelates are stable in cell-medium, highly toxic in vitro against human carcinoma cell lines and have strong in vivo antitumor efficacy in a mouse cervical-cancer model. 15a,16 Based on the above considerations we thus became interested to explore the utilization of our mixed ligand system on zirconium alkoxides to study stability and potential cytotoxicity of the resulting complexes. Herein we present the first synthesis and preliminary bio evaluation of three novel heptacoordinate salan Zr(IV) bis-chelates. (1)1) while the N-Zr-N angle (average 67.48(7)1) of [(L1) 2 Zr] is more acute than in above bis(salan) complexes (average 70.4 (1)1). 19 This situation results from the steric repulsion of the tertiary amines in [(L1) 2 Zr] which forces both salan ligands in a zig-zag like conformation. This contrasts with the binding geometry in bis(salan) and bis(salen) complexes where the disposition of the ligands resembles two interpenetrating planes. 18, 19 The structures of [L1-3Zr(dipic)] were confirmed by 1 H-NMR analysis and resembles closely those found for their titanium congeners with two pairs of doublets, each representing a pair of diastereotopic benzylic and bridgehead protons. 15,16b Except for a slight upfield shift for the benzylic protons, the spectra of [L1Zr(dipic)] and [L1Ti(dipic)] are nearly indistinguishable (see Fig. S23 , ESI †). The structure was further proven by X-ray diffraction In contrast to the rather sensitive complexes above, stability of the dipic-stabilized heptacoordinate [L1Zr(dipic)] could be assessed by UV-vis spectroscopy in the concentration range of 10 À5 mol l À1 utilizing larger amounts of water. Consequently, UV-vis spectra were recorded after the addition of 100.000 eq. of water in intervals of 1 hour. During the measurement period of 140 h a slow decrease of l max at 250 nm with an overall decrease of absorption over the whole spectral range was observed. The decay followed a rate law of higher order which prevented the exact determination of t 1/2 . Nevertheless, when exposed to such a large excess of water, the half-life of [L1Zr(dipic)] is still in the range of several hours and outperforms the other Zr-complexes under study by several orders of magnitude (Fig. S24, ESI †) .
To explore the possible endpoint of hydrolysis, we exposed [L1Zr(dipic)] to neat water for prolonged time. To facilitate reaction of the suspension, the mixture was subjected to ultrasound irradiation every 24 hours for 30 min during the first 4 days. Under these conditions a 50 : 50 mixture of [L1Zr(dipic)] and free salan was detected after 24 h. Longer exposure led to complete liberation of the salan ligand with only minute quantities of intact [L1Zr(dipic)] left. To identify possible intermediates of the hydrolysis, a defined amount of [L1Zr(dipic)] was incubated with a range of water concentrations spanning three orders of magnitude. Products were analyzed by means of 1 H-NMR and LDI-TOF mass spectroscopy. To this end, 30 mg of complex were dissolved in 30 ml THF and 5, 10, 100 and 1.000 eq. water were added. After continuous stirring at r.t. for 6 days the solvent was removed and the remainder taken up in CDCl 3 . While the lowest water concentrations (5-100 eq.) only led to limited hydrolysis, the experiment with 1.000 eq. of water showed considerable formation of hydrolysis products. Besides the starting complex and free salan ligand, an apparent highly symmetric new species showing the typical 1 H-NMR pattern of a salan-complex was identified. The three constituents were found in a 1 : 1.4 : 2 ratio (Fig. S25 , ESI †). The newly formed complex was identified directly from the NMR-sample as the monomeric bishydroxo zirconium salan [L1Zr(OH) 2 ] by LDI-TOF mass spectroscopy (Fig. S26 , ESI †). Similar mono-molecular Zr-hydroxo-species were previously isolated and characterized.
21 Apparently, the bishydroxo species is a transient intermediate in the hydrolysis of [L1Zr(dipic)] since it was not detected in experiments applying higher water concentrations as described above. All Zr(IV) complexes were preliminary tested for their cytotoxic activity utilizing an AlamarBlue-based proliferation assay (details see ESI †). 22 The cytotoxicity was studied in two different -complexes. 9b This might indicate an efficient cellular uptake mechanism for the heavier group IV-complexes. The sterically more demanding [L2Zr(dipic)] showed about 10 times lower cytotoxicity than [L1Zr(dipic)] (entry 2). Enhancing the sterical demand even further like in [L3Zr(dipic)] with 2,4-di-tertbutyl substitution on the salan backbone, led to a complete loss of cytotoxicity in both cell lines. A systematic decrease in cytotoxic activity with increased sterical demand was previously reported for octahedral salan Ti(IV) bisalkoxides. In summary, we have synthesized three members of a new type of heptacoordinate salan dipic Zr(IV)-bis-chelate. Their structures were elucidated by NMR and X-ray data analysis. Preliminary in vitro biological evaluation against two human cell lines reveals that heptacoordinate [L1Zr(dipic)] exhibits excellent anticancer activity in the range of cisplatin. The lack of labile ligands suggests a different mode of action to that of previously reported titanium salan bisalkoxides. In contrast to the non-active complexes, [L1Zr(dipic)] exhibits improved aqueous stability with a t 1/2 in the range of several hours. However, during long term exposure of [L1Zr(dipic)] to varying amounts of water a bishydroxo Zr(IV) complex was identified by mass and 1 H-NMR spectroscopy as the major intermediate of hydrolysis. Further studies towards the identification of other stabilizing ligand systems and their application in the development of zirconium based antitumoral drugs are ongoing work.
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